Showing results (231-240 of 398) with videos related to

Sort By:
Pageof 40
World Journal of Gastroenterology|February 17, 2015
Retrospective analysis of extra-gastrointestinal stromal tumorsJun Ho Yi, Byeong-Bae Park, Jung Hun Kang, et al.
Cancer Chemotherapy and Pharmacology|December 12, 2018
Safety and efficacy of trastuzumab administered as a 30-min infusion in patients with HER2-positive advanced gastric cancerSung Yong Oh, Suee Lee, Seok Jae Huh, et al.
American Journal of Clinical Oncology|December 15, 2004
Docetaxel plus cisplatin as second-line therapy in metastatic or recurrent advanced gastric cancer progressing on 5-fluorouracil-based regimenSe Hoon Park, Won Ki Kang, Hyo Rak Lee, et al.
Cancer Chemotherapy and Pharmacology|April 29, 2011
Phase I trial of capecitabine plus everolimus (RAD001) in patients with previously treated metastatic gastric cancerTaekyu Lim, Jeeyun Lee, Duk Joo Lee, et al.
Translational Oncology|January 30, 2019
Combination of Docetaxel Plus Savolitinib in Refractory Cancer Patients: A Report on Phase I TrialSeung Tae Kim, Sujin Lee, Minhwa Park, et al.
The Lancet. Oncology|November 7, 2017
Olaparib in combination with paclitaxel in patients with advanced gastric cancer who have progressed following first-line therapy (GOLD): a double-blind, randomised, placebo-controlled, phase 3 trialYung-Jue Bang, Rui-Hua Xu, Keisho Chin, et al.
Cancer Research and Treatment|January 16, 2018
Phase II Study of Dovitinib in Patients with Castration-Resistant Prostate Cancer (KCSG-GU11-05)Yoon Ji Choi, Hye Sook Kim, Se Hoon Park, et al.
JCO Global Oncology|March 10, 2020
Treatment of Patients With Late-Stage Colorectal Cancer: ASCO Resource-Stratified GuidelineE Gabriela Chiorean, Govind Nandakumar, Temidayo Fadelu, et al.
Cancer Chemotherapy and Pharmacology|August 10, 2005
Anemia is the strongest prognostic factor for outcomes of 5-fluorouracil-based first-line chemotherapy in patients with advanced gastric cancerSe Hoon Park, Jeeyun Lee, Se Hoon Lee, et al.
BMC Cancer|December 14, 2012
Unique perception of clinical trials by Korean cancer patientsSu Jin Lee, Lee Chun Park, Jeeyun Lee, et al.
Pageof 40